Charles River Laboratories International (CRL) Non Operating Income (2009 - 2025)
Charles River Laboratories International (CRL) recorded quarterly Non Operating Income of $12.1 million in Q4 2025, up 153.49% quarter-over-quarter from -$22.6 million in Q3 2025, and up 153.29% on a YoY basis from $4.8 million in Q4 2024.
Charles River Laboratories International (CRL) Non Operating Income (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Non Operating Income history runs 17 years deep, the most recent figure standing at $12.1 million for Q4 2025.
- In Q4 2025, Non Operating Income rose 153.29% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at -$22.6 million (down 36.66% YoY), while the FY2025 annual figure was -$22.6 million, down 36.66% from the prior year.
- Non Operating Income was $12.1 million for Q4 2025 at Charles River Laboratories International, up from -$22.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $115.5 million in Q4 2022 to a low of -$39.8 million in Q2 2022.
- Historically, Non Operating Income has averaged $2.6 million across 5 years, with a median of -$3.0 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income jumped 5476.59% in 2022, then tumbled 972.61% in 2025.
- A 5-year view of Non Operating Income shows it stood at $2.1 million in 2021, then surged by 5476.59% to $115.5 million in 2022, then slipped by 6.76% to $107.7 million in 2023, then slumped by 121.07% to -$22.7 million in 2024, then soared by 153.29% to $12.1 million in 2025.
- The last three Non Operating Income figures came in at $12.1 million (Q4 2025), -$22.6 million (Q3 2025), and $154000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -4.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 9.60 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 7.33 Mn |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 12.10 Mn |
| Sep 27, 2025 | -22.62 Mn |
| Jun 28, 2025 | 154,000.00 |
| Mar 29, 2025 | -12.21 Mn |
| Dec 28, 2024 | -22.71 Mn |
| Sep 28, 2024 | 2.59 Mn |
| Jun 29, 2024 | -2.24 Mn |
| Mar 30, 2024 | 5.83 Mn |
| Dec 30, 2023 | 107.74 Mn |
| Sep 30, 2023 | -6.26 Mn |
| Jul 1, 2023 | -2.66 Mn |
| Apr 1, 2023 | -3.28 Mn |
| Dec 31, 2022 | 115.55 Mn |
| Sep 24, 2022 | -16.62 Mn |
| Jun 25, 2022 | -39.78 Mn |
| Mar 26, 2022 | -28.63 Mn |
| Dec 25, 2021 | 2.07 Mn |
| Sep 25, 2021 | -16.21 Mn |
| Jun 26, 2021 | 5.97 Mn |
| Mar 27, 2021 | -27.72 Mn |